Veracyte reported $62.54M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US $ 163.06M 6.12M
Agilent A:US $ 1813M 229M
Anika Therapeutics ANIK:US $ 26.99M 2.8M
Arrowhead Research ARWR:US $ 138.86M 1.82M
Biocept BIOC:US $ 14.1M 2.32M
Bruker BRKR:US $ 880.5M 58M
Exact Sciences EXAS:US $ 480.95M 36.12M
Heron Therapeutics HRTX:US $ 93M 21.94M
Illumina ILMN:US $ 1490M 397M
Immunogen IMGN:US $ 84.12M 16.83M
Intrexon XON:US $ 25.6M 9.04M
Karyopharm Therapeutics KPTI:US $ 66.34M 7.38M
Laboratory Of America LH:US $ 2641.5M 141.4M
Ligand Pharmaceuticals LGND:US $ 42.58M 0.91M
Myriad Genetics MYGN:US $ 166M 38.3M
Rigel Pharmaceuticals RIGL:US $ 59.22M 4.33M
Sangamo Biosciences SGMO:US $ 118.53M 9.36M
Siemens SIE:GR € 42684M 1991M
Sonic Healthcare SHL:AU $ 2B 220.52M
Thermo Fisher Scientific TMO:US $ 12070M 1366M
Veracyte VCYT:US $ 62.54M 1.61M
Waters WAT:US $ 687.83M 7.32M